Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of compound to preparation of mTOR inhibitor

A compound and inhibitor technology, applied in the field of medicinal chemistry, can solve the problems of large toxic side effects, instability, high toxicity, etc., and achieve the effect of controlling proliferation

Active Publication Date: 2015-05-13
绍兴康岳生物科技有限公司
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Although some compounds have been reported in the prior art that can inhibit mTOR signal transduction, there are many toxic side effects and poor pharmacological parameters (such as high toxicity to normal cells and instability in aqueous phase), thus limiting their application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of compound to preparation of mTOR inhibitor
  • Application of compound to preparation of mTOR inhibitor
  • Application of compound to preparation of mTOR inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1 SC06 inhibits the proliferation of myeloma and leukemia cell lines and lymphoma cell lines

[0032] Different multiple myeloma cell lines (RPMI-8226, JJN3, KMS11, LP1, OCI-My5, OPM2, U266), leukemia cell lines (AML2, K562, NB4, THP1) and lymphoma cell lines (Jurkat) were tested by SC06 (20 μM, the drug was prepared with 100% DMSO and diluted in 0.5% DMSO solution) after treatment for 72 hours, add thiazolium blue (MTT) and incubate for 2 to 4 hours, add MTT buffer, read the plate after overnight incubation to calculate the cell survival rate ( Three replicate wells for each group of cells). attached figure 1 This is the cell survival curve (MTT) graph of different myeloma and leukemia cell lines treated with SC06. It can be seen that SC06 can effectively inhibit the proliferation of multiple myeloma cells and leukemia cells and induce tumor cell apoptosis.

Embodiment 2

[0033] Example 2 SC06 inhibits the growth of solid tumor cell lines

[0034] Different solid tumor cell lines (lung cancer (A549, H460), cervical cancer (HeLa), prostate cancer (PC3), ovarian cancer (SKOV3), breast cancer (T47D) were treated with SC06 (20 μM, the drug was prepared with 100% DMSO Diluted in 0.5% DMSO solution) after treatment for 72 hours, photographed with an inverted fluorescence microscope. Attached figure 2 Microscopic images of different solid tumor cell lines treated with SC06. It can be seen that SC06 can effectively inhibit the proliferation of various tumor cells and induce tumor cell apoptosis.

Embodiment 3

[0035] Example 3 SC06 inhibits the phosphorylation of mTOR

[0036] Different multiple myeloma cell lines (LP1, OPM2, JJN3 and RPMI-8226) were treated with SC06 (20 μM, the drug was prepared in 100% DMSO and diluted in 0.5% DMSO solution) for 24 hours, the cells were collected, and the total protein, the expression of phosphorylated mTOR (p-mTOR) and total mTOR was detected by Western blot; attached image 3 It is the western blot (Western Blot) figure after different tumor cells are treated, SC06 can significantly inhibit the phosphorylation level of mTOR, showing a significant inhibitory effect on it.

[0037] Different tumor cells were cultured overnight in low serum (0.5%), treated with SC06, S14161 and rapamycin (Rapamycin) (10 nM) for 2 hours, then treated with insulin-like growth factor (IGF-1) for 15 minutes, and the cells were collected. The total protein was extracted, and the expression of phosphorylated mTOR (p-mTOR) was detected by Western blot. GAPDH was used as...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a compound to the preparation of an mTOR inhibitor, belongs to the field of medicine, and in particular relates to the application of a compound SC06 to the preparation of the mTOR inhibitor. The compound has the functions of inhibiting an mTOR signal channel so as to induce apoptosis of tumors and inhibiting tumor growth. The compound SC06 can inhibit the proliferation and growth of tumor cells and can effectively induce the apoptosis of tumor cells, therefore showing a therapeutic action on tumors.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry and relates to an mTOR inhibitor, in particular to the application of a compound as an mTOR inhibitor. Background technique [0002] At present, tumors are increasingly threatening human life and health. In 2012, my country released the annual report on tumor incidence registration for the first time. The annual report shows that there are about 3.12 million new cancer cases in my country every year, among which, the national average is 8550 people every day, and 6 people are diagnosed with tumors every minute. At the same time, the national cancer mortality rate is 1.8054 / 100,000, with 2.7 million cases of cancer death each year. Among them, the probability of death due to tumors among Chinese residents is 13%, that is, 1 out of every 7 to 8 people dies due to tumors. In addition to the morbidity, the reason for the high mortality rate of tumors is the lack of effective anti-tumor drugs. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4439A61P35/00A61P35/02C07D401/12
Inventor 毛新良韩昆昆
Owner 绍兴康岳生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com